Special Edition: What's Next—Cortisol, Metabolism & Future Innovation, Part 4

Special Edition: What's Next—Cortisol, Metabolism & Future Innovation, Part 4

May 19, 2026 · 27 min

About this episode

This episode explores the effects of hypercortisolism on difficult-to-treat diabetes and resistant hypertension.

Is hypercortisolism the hidden culprit in a significant proportion of both difficult-to-treat diabetes and resistant hypertension? In part 4 of our special series, Dr. Neil Skolnik speaks with John Buse, MD to explore the effects of hypercortisolism, until just recently considered a vanishingly rare condition. This special episode is sponsored with support from Corcept . Please listen to the episodes by clicking on the podcast player below or by freely subscribing to Diabetes Core Update via Apple Podcasts , Amazon Music , Spotify , or your preferred podcast platform. Presented by: Neil Skolnik , MD, Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health John Buse , MD, The Verne S. Caviness Distinguished Professor and director of the Diabetes Center at the University of North Carolina at Chapel Hill School of Medicine, a past president of medicine & science at the American Diabetes Association (ADA), and recipient of the ADA Outstanding Achievement in Clinical Diabetes Research Award Selected references: Prevalence of Hypercortisolism in…

Sponsors

Corcept

More episodes of Diabetes Core Update

Explore listener stats, chart rankings, contacts and more on the Diabetes Core Update podcast page.